CD3 proteins may have redundant as well as speci®c contributions to the intracellular propagation and ®nal effector responses of TCR-mediated signals at different checkpoints during T cell differentiation. We report here on the participation of CD3g in the activation and effector function of human mature T lymphocytes at the antigen recognition checkpoint. Following TCR±CD3 engagement of human CD3g-de®cient T cell lines, and despite their lower TCR±CD3 surface levels compared to normal controls, mature T cell responses such as protein tyrosine phosphorylation and the regulation of expression of several cell surface molecules, including the TCR±CD3 itself, were either normal or only slightly affected. In contrast, other physiological responses like the speci®c adhesion and concomitant cell polarization on ICAM-1-coated dishes were selectively defective, and activation-induced cell death was increased. Our data indicate that CD3g contributes essential specialized signaling functions to certain mature T cell responses. Failure to generate appropriate interactions may abort cytoskeleton reorganization and initiate an apoptotic response.
Introduction
Mature ab T lymphocytes recognize pathogen-derived peptides on antigen-presenting cells by means of a multimeric membrane protein ensemble termed the TCR±CD3 complex. The ab TCR±CD3 complex includes two clonally distributed variable chains that directly interact with antigen (TCRa and TCRb), and four invariant polypeptides that regulate assembly, expression and signal transduction (CD3g, CD3d, CD3e and CD3z) (1) . TCR±CD3 engagement initiates an intricate cascade of signal transduction events involving a growing family of downstream intracellular mediators (both adaptors and enzymes), which may result either in T cell activation, proliferation and effector function, or in anergy, or in apoptosis, depending on as yet unclear differences in the cytosolic integration of extracellular information (2, 3) . Signals relayed through the very same structure or through immature variants thereof (such as the pre-TCR sensor) are also responsible much earlier, during intrathymic development, for T cell selection (4) . However, the relative contribution and intracellular connections of each invariant chain during TCR±CD3-mediated signaling are still a matter of debate (5, 6) .
CD3 chains may have partially redundant functions, as all CD3 components share in their cytoplasmic tails at least one immunoreceptor tyrosine-based activation amino acid motif (ITAM), which accounts for the signaling properties of the individual chains (7) . Indeed, isolated ITAM from CD3e or CD3z coupled to quimeric receptors, which lack all other CD3 subunits, transduce ef®ciently certain activation signals in T lymphocytes (8, 9) . Zap-70, one of the enzymes recruited earlier to TCR±CD3 complexes, can bind to CD3 chains other than z (10) and certain ITAM (such as those of CD3g, CD3d or CD3z) are altogether dispensable for T cell activation or differentiation (11±13).
However, CD3 molecules may also perform specialized functions, as ITAM sequences belonging to different CD3 chains show different af®nities for downstream adaptors and enzymes, as well as different signaling functional outcomes [such as substrate tyrosine phosphorylation, apoptosis or calcium mobilization, reviewed in (11)]. Isolated CD3e or CD3z ITAM cannot induce mature T cell proliferation, suggesting that certain responses require a minimum complement of such ITAM (14, 15) . The specialized functions may not map to the ITAM, since a tail-less CD3d has been shown to rescue the selective defect observed in TCR±CD3 signaling to ERK, but not other, MAP kinases when CD3d is lacking during thymocyte selection (12) .
Lastly, ablation experiments in mice suggest that redundant and speci®c roles for the invariant chains of the TCR±CD3 complex may co-exist, and can be exposed by carefully probing activation events at the different developmental checkpoints (6) .
In contrast to their murine homologues, humans with natural CD3g and CD3e de®ciencies have a substantial number of mature peripheral blood T lymphocytes, allowing the analysis of signal speci®cation by incomplete receptors at the last TCR±CD3-mediated checkpoint, i.e. antigen recognition (16) . Our previous studies in human CD3g-de®cient primary T cells, IL-2-dependent T cell lines and Herpesvirus saimiri (HVS)-transformed T lymphocytes indicated that, despite their decreased TCR±CD3 expression levels, several mature T cell responses were normally induced via their mutant TCR± CD3, including calcium¯ux, cytotoxicity, up-regulation of CD69 or CD154, proliferation and synthesis of speci®c cytokines, such as tumor necrosis factor (TNF)-a. In contrast, TCR±CD3-induced synthesis of other cytokines like IL-2, and phorbol myristate acetate (PMA)-induced TCR±CD3 downregulation, were severely impaired (17±20). These results suggested a specialized role for CD3g in coupling the remaining TCR±CD3 chains to these particular signaling pathways. We have now extended these studies and explored the participation of CD3g in other relevant TCR±CD3-induced T lymphocyte responses, such as regulation of the expression of several surface molecules including the TCR, adhesion, apoptosis and protein tyrosine phosphorylation in transformed CD3g-de®cient T lymphocytes.
Methods

T cell lines
HVS (strain 488C)-transformed T cell lines were derived from peripheral blood lymphocytes of a healthy congenital CD3g-de®cient (g ± ) individual or normal donors (g + ), as previously described (17, 18) . The CD4 + and CD8 + T cell lines used in the experiments had been cultured for 6 years (DSF4, CD4 + g ± ), 5 years (CTO, CD8 + g + and DSF8, CD8 + g ± ), 4 years (AGU and RUT, both CD4 + g + ) or 3 years (APC, CD4 + g + , and DPR, MAI, SLM and ANZ, CD8 + g + ). Cells have always been grown in parallel in 1:1 Panserin 401:RPMI [from PAN Biotech (Aidenbach, Germany) and Gibco/BRL (Paisley, UK) respectively] medium with 40 IU/ml human rIL-2 (Frederick Cancer Research and Development Center, NCI, Frederick, MD), 10% FCS (Flow, Rockville, MD, UK) and 1% glutamine (Biowhittaker, Verviers, Belgium) replaced every 3±4 days. All experiments were performed on resting cells, generated by starving cells overnight in Panserin/RPMI with 2% FCS, but no IL-2, the day before medium replacement was due. Cells were washed twice in PBS and resuspended in Panserin/RPMI 10% FCS without IL-2 before use.
Antibodies and¯ow cytometry
The expression of different surface markers was studied bȳ ow cytometry according to a standard procedure (19) . The following mAb were used (30 min, 4°C): CD2, CD5, CD8a, CD25 and CD71 from Caltag (Burlingame, CA); CD3 (UCHT1) and CD18 from Immunotech (Marseille, France); and CD3 (Leu4), CD4 (Leu3a), CD45R0 and CD80 (BB1/B7) from Becton Dickinson (Mountain View, CA). CD3 (F101.01) hybridoma supernatant was a generous gift of Dr Bent Rubin (CHU de Purpan, Toulouse, France). All commercial antibodies were FITC-or phycoerythrin-conjugated and, for F101.01, an FITC-or phycoerythrin-conjugated goat antimouse IgG (H + L) from Caltag was used. Background uorescence was de®ned in all cases with an isotype-matched irrelevant mAb from Caltag. Cells were washed twice in PBS and analyzed in an Epics Elite Analyzer cyto¯uorometer (Coulter, Hialeah, FL).
For comparative stainings we used the MFI, de®ned as the average¯uorescence value of the corresponding mAb referred to the logarithmic scale of¯uorescence intensity along the x-axis of the histograms.
To follow the TCR±CD3-induced regulation of several surface markers, 1 Q 10 6 resting cells/ml were incubated at 37°C/5% CO 2 in 96-well round-bottom plates (10 5 cells/well, in triplicate) in the presence of 1 mg/ml plastic-immobilized CD3-speci®c mAb (puri®ed UCHT1) or (as a negative control) of an immobilized isotype-matched irrelevant mAb (Caltag), for several time periods (20±48 h). Cells were then harvested, washed twice in PBS 1% FCS and analyzed for the expression of each surface molecule by¯ow cytometry. Expression changes were recorded as the percentage of mAb binding (estimated as MFI) in CD3-stimulated samples relative to the unstimulated control as a function of time.
TCR±CD3 down-regulation and immunoprecipitation
CD3-induced TCR±CD3 down-regulation was performed as described previously (21) . Brie¯y, 1 Q 10 6 resting cells/ml were incubated at 37°C/5% CO 2 in 96-well round-bottom plates (10 5 cells/well) in the presence of different dilutions of soluble CD3-speci®c mAb (Leu4 hybridoma supernatant kindly donated by Dr B. Alarco Â n, Centro de Biologõ Âa Molecular, Madrid, Spain) or (as a negative control) of soluble isotype-matched irrelevant mAb (Caltag) for several time periods (2±30 h). Cells were washed twice in PBS/1% FCS, incubated on ice with 5 ml of the same supernatant (Leu4) for 45 min, stained with phycoerythrin-conjugated goat antimouse IgG for 45 min and analyzed by¯ow cytometry. Expression changes were recorded as the percentage of Leu4 binding (estimated as MFI) in CD3-stimulated samples relative to the unstimulated control.
PMA-induced TCR±CD3 down-regulation was done as described (22) . Brie¯y, 5 Q 10 5 resting cells/ml were incubated at 37°C (i) for 30 min in the presence or absence of increasing amounts of PMA (20±160 ng/ml; dose±response experiments) or (ii) in the presence or absence of 20 ng/ml PMA for several time periods (30±120 min; kinetic analyses). After two washings with PBS/1% FCS, CD3 expression was monitored with phycoerythrin-conjugated Leu4 by¯ow cytometry. Results are given as the percentage of anti-CD3 binding in PMA-treated cells relative to unstimulated cells.
To analyze the surface CD3g and CD3d levels after PMA treatment, 40 Q 10 6 resting cells were incubated with 20 ng/ml PMA for 30 min and monitored with Leu4 for TCR downregulation relative to untreated cells, as explained above. The cells were then surface radioiodinated, lysed, immunoprecipitated with APA 1/1 (anti-CD3 ascitic¯uid, donated by B.
Alarco Â n) and digested with N-glycanase before electrophoresis, essentially as described (20) . CD3g:CD3d ratios were estimated by electronic densitometry of the corresponding deglycosylated proteins on a Geldoc 2000 analyzer (Bio-Rad, Hercules, CA).
Cell attachment assays
Cell adhesion assays were performed as described (23) . First, 96-well¯at-bottom plates (Costar, Cambridge, MA) were precoated overnight at 4°C with 6 mg/ml ICAM-1±Fc in adhesion buffer (20 mM Tris±HCl and 150 mM NaCl, pH 8.2), blocked with 1% BSA in adhesion buffer for 1 h at room temperature and washed twice with PBS. Second, 1 Q 10 6 resting cells/ml were incubated on ice for 30 min in the presence or absence (spontaneous adhesion) of (i) anti-CD3-speci®c mAb (1 mg/ml UCHT1 or 1/50 dilution F101.01), washed twice in PBS to remove mAb excess and cross-linked with 2 mg/ml of goat anti-mouse IgG for 10 min at 37°C), (ii) 10 mg/ml of the LFA-1-activating CD18-speci®c mAb KIM-127 (maximum adhesion control) or (iii) 100 nM phorbol ester PDBu (Sigma, St Louis, MO). Treated and untreated cells were incubated in the coated wells (3 Q 10 5 cells/well in duplicates) for several time periods (15±90 min) at 37°C. Plates were gently washed 4 times in prewarmed PBS, and bound cells were ®xed with 1% formaldehyde in cold PBS and stained with 0.5% crystal violet in 2% methanol. Images were acquired with a SPOT-2 color digital camera (Diagnostic Copy, Sterling Heights, MI) coupled to an Axioplan-2 microscopy (Carl-Zeiss, Jena, Germany) at Q20. Electronic cell counting of at least two representative ®elds was performed with MetaMorph software (MetaMorph Imagin System; Universal Imaging, Downingtown, PA). The percentage of speci®c adhesion was calculated for each time point as the ratio of 100 Q [(experimental ± spontaneous cell binding)/(maximum ± spontaneous cell binding)]. Cell polarization, de®ned as the appearance of long, frequently unique, projections, was calculated from 10 randomly chosen ®elds of each condition by direct counting of total cells (500±600) at Q40. Only clearly polarized cells were considered.
Apoptosis assays
Resting cells (5 Q 10 5 /ml) were incubated in 96-well roundbottom plates (1 Q 10 5 cells/well in triplicates) in the absence (negative control) or presence of 1 mg/ml plastic-immobilized CD3-speci®c mAb (UCHT1; Immunotech, Marseille, France), 10 ng/ml PMA (Sigma) plus 750 ng/ml ionomycin (Sigma) or 1 mg/ml phytohemagglutinin (Difco, Detroit, MI) for several time periods (18±48 h) at 37°C/5% CO 2 . Apoptosis was analyzed using a commercial kit for such purpose (Bender Medsystems; Sigma). Brie¯y, after stimulations, 2 Q 10 5 cells were washed once in PBS, resuspended in 200 ml binding buffer (10 mM HEPES/NaOH, pH 7.4, 140 mM NaCl and 2.5 mM CaCl 2 ), in the presence of 5 ml FITC-conjugated Annexin V, transferred to cytometer tubes and incubated for at least 10 min in the dark at room temperature. Then cells were washed once in binding buffer and resuspended in 300 ml of the same solution. Finally, 15 ml of propidium iodide (PI, 20 mg/ ml) was added to the tubes and cells were analyzed by¯ow cytometry. Untreated cells were used as negative apoptosis control. Necrotic (N) cells were distinguished from apoptotic (A) cells, among Annexin V + lymphocytes, by their susceptibility or resistance to PI staining respectively. Relative cell death was calculated as the percentage of apoptotic or necrotic cells after stimulation relative to unstimulated cells (spontaneous cell death) as a function of time. Results are given as the mean T SD of three independent experiments.
Phosphorylation assays
Tyrosine-phosphorylated proteins in response to anti-CD3 treatment were detected by Western immunoblotting of cell lysates with the anti-phosphotyrosine-speci®c mAb 4G10 (kindly donated by N. Taylor, Institut de Genetique Moleculaire, CNRS, Montpellier) as described elsewhere (24) . Brie¯y, 6 Q 10 6 resting cells/ml were stimulated with a CD3-speci®c mAb (50 ml of an 1/50 dilution of Leu4 supernatant) at 37°C for several time periods (1±10 min). Cells were then washed in cold PBS and lysed on ice with 500 ml of lysis buffer (1% NP-40, 140 mM NaCl, 10 mM Tris pH 7.5, 5 mM EDTA, 10 mM PMSF, 1 mg/ml aprotinin and 1 mM sodium orthovanadate) for 30 min. Lysates were then centrifuged at 12,000 g for 30 min and supernatants containing the NP-40-soluble fraction were subjected to SDS±PAGE on 7.5% gels. Proteins were then transferred onto a nitrocellulose membrane using a semidry transfer system for 30 min at 15 V (Bio-Rad). Immunoblots were stained with Ponceau S to control the quality of the transfer and then blocked with 0.5% blocking reagent (Roche, Mannheim, Germany) in PBS with 1% Tween 20. After 3 washes in TBS, blots were incubated with 1/100 4G10 in 0.5% blocking reagent, 0.1% Tween 20 in TBS for 1 h at room temperature and washed 4 times with 0.1% Tween 20 in TBS. Bound anti-phosphotyrosine mAb was developed with a horseradish peroxidase-labeled sheep anti-mouse IgG (Amersham, Little Chalfont, UK), and detected by enhanced chemiluminescence (ECL; Amersham). The ®lms were electronically scanned on a Bio-Rad Geldoc 2000 analyzer (Bio-Rad) to determine the intensity and molecular weight of each protein.
Results
Phenotype of CD3g-de®cient HVS-transformed mature T lymphocytes
Normal (g + ) and mutant (g ± ) T cells expressed comparable levels of several relevant molecules (Fig. 1) . However, CD45RO was strongly overexpressed in transformed CD8 + g ± cells, perhaps as a compensatory mechanism to ensure transformation (19, 25) , as such difference was not observed in primary T cells [(26) and Zapata, unpublished] . CD3 expression levels were clearly positive but lower in g ± (particularly CD8 + ) than in g + T cells with all tested monoclonals, as described (20) .
TCR±CD3-induced regulation of cell surface molecules
Signaling through the mutant g ± TCR±CD3 complex was next studied by analyzing changes in the surface levels of several cell surface molecules after CD3 engagement (Fig. 2) . The results indicated that g ± T cells were essentially normal by this functional assay, both for the up-regulation (CD25, CD71 and CD80) or down-regulation (CD4/8) of the analyzed molecules.
However, a slight but consistent delay was observed in g ± cells for the up-regulation of CD25 in CD8 + cells, or for the downregulation of CD4 or CD8 in the respective lineages. Larger differences in CD25 induction were observed when other normal controls were used for comparison (data not shown). Impaired CD3-induced regulation of CD25 has been reported previously in murine g ± thymocytes (27) . Lower TCR±CD3 expression by g ± T cells did not affect the induction of CD71, suggesting that the observed delay in the regulation of other cell surface molecules was CD3g speci®c. We conclude that g ± T cells can regulate the expression of several cell surface molecules after TCR±CD3 triggering, although with delayed kinetics in some cases.
Defective phorbol ester-induced and reduced TCR±CD3-induced CD3 down-regulation
In a second set of functional experiments, g ± T cells were stimulated with anti-CD3 to analyze the down-regulation of the TCR±CD3 itself. As a control, cells were stimulated with phorbol ester PMA, which is known to be strictly dependent on CD3g for TCR±CD3 down-regulation (22, 28) . The results demonstrated that g ± T cells were resistant to PMA treatment (Figs 3B and 4A), whereas they clearly down-regulated their TCR±CD3 upon CD3 (Leu4) engagement (Fig. 3) . However, TCR±CD3 down-regulation by g ± T cells was always lower than controls (Fig. 3A) . Note that the clear differences in Leu4 staining between CD4 + and CD8 + g ± cells (Fig. 1) did not affect their relative TCR±CD3 down-regulation levels, suggesting that signaling for this particular function was independent of the number of engaged surface TCR±CD3 complexes.
PMA stimulation consistently down-regulates~50% of normal surface TCR±CD3 complexes, but hardly any when CD3g is absent (Fig. 4A) (22,29±31) . It has been proposed that the TCR±CD3 complex is a mixture of at least two biochemically independent isoforms: abgez and abdez (32). It was therefore conceivable that only the former (i.e. g-containing) TCR±CD3 isoforms were susceptible to PMA-induced internalization. To test this hypothesis, the surface g:d content ratio of g + T cells (and, as a control, of g ± T cells) was evaluated by immunoprecipitation and N-glycanase digestion before and after PMA treatment (Fig. 4B) . The results showed that the g:d ratio in g + T cells was not modi®ed by exposure to PMA, suggesting that the putative g-containing and d-containing TCR±CD3 isoforms do not exist or are not functionally independent by this assay.
Increased TCR±CD3-and lectin-induced apoptosis TCR ligand-induced apoptosis kinetics using anti-CD3 or PHA was next analyzed. In contrast to anti-CD3, PHA binding to g + and g ± T lymphocytes was similar (data not shown). As a TCR± CD3-independent stimulus, cells were incubated with phorbol ester PMA plus calcium ionophore ionomycin. Figure 5A depicts the induction of necrosis (N) and apoptosis (A) relative to unstimulated cells. The results showed that both membrane stimuli (anti-CD3 and PHA), but not PMA + ionomycin, induced a stronger apoptotic response (A plots) throughout the analyzed timescale (see A plots in Fig. 5A , with representative pro®les in Fig. 5B, A quadrants) . The relative induction of necrosis, however, was similar in g ± and g + T cells (N plots), although unstimulated transformed g ± T cell samples showed a high proportion of spontaneously necrotic, but not apoptotic, cells (Fig. 5B) . We conclude that g ± T cells are speci®cally more prone to TCR±CD3-induced apoptosis than g + T cells.
Defective cytoskeleton control and TCR±CD3-induced speci®c adhesion
Signals propagated by the TCR±CD3 complex have been shown to functionally up-regulate the integrin LFA-1 (CD11a/ CD18) and to induce adhesion on ICAM-1 (33). We thus next analyzed whether this physiological function was affected in the mutant g ± T cells. As a control, cells were stimulated with an activating mAb speci®c for CD18 (KIM-127, anti-LFA-1 in Fig. 6 ) or with phorbol ester PDBu, both of which are known to induce LFA-1-mediated adhesion to ICAM-1. Importantly, unstimulated g ± and g + T cells originally expressed similar amounts of CD18 (Fig. 1) and CD11a (not shown), and their basal adhesion to ICAM-1 was also comparable (Fig. 6B) . As shown for untransformed T cells (33, 34) , speci®c adhesion by transformed g + T cells to ICAM-1-coated plates increased upon LFA-1 activation by any of the three stimuli (anti-CD3, anti-LFA-1 or PDBu), albeit with different kinetics and relative strength (Fig. 6A) . In contrast, the number of ICAM-1-attached g ± T cells did not change after stimulation with two different anti-CD3 mAb (UCHT1, Fig. 6 and F101 .01, not shown), whereas an increase comparable to that of g + T cells was evident with anti-LFA-1 or PDBu. We conclude that TCR±CD3-mediated signaling that led to enhanced adhesion onto ICAM-1 was selectively defective in g ± T cells.
The augmented adhesion was accompanied by profound morphological changes characterized by polarization (long, frequently unique, projections) in treated g + T cells (Fig. 6A  and B) (35) . In contrast, almost no polarization was observed in g ± T cells with anti-CD3, whereas it was present (with delayed kinetics) when stimulated with anti-LFA-1. Anti-CD3 stimulation, however, did induce spreading in g ± T cells, con®rming that the mutant TCR±CD3 complex transduced certain signals involved in morphology control. Interestingly, PDBu stimulation did not result in any polarization of g ± T cells, despite their normal adhesion behavior, indicating that these two activation events are dissociated in g ± T cells. Normal adhesion induction with no cellular polarization has been reported previously in anti-LFA-1-stimulated T lymphoblasts treated with tyrosine kinase inhibitors (33) . Thus, the results in g ± T cells suggested an abnormal cytoskeleton control via TCR±CD3, which could not be corrected by direct protein kinase C (PKC) activation.
TCR±CD3-induced tyrosine phosphorylation
Next, we analyzed protein tyrosine phosphorylation following TCR±CD3 triggering (36, 37) . The results (Fig. 7) indicated that g ± T cells were essentially normal in terms of tyrosine phosphorylation speci®city (arrows), although the response was slightly unsustained for certain proteins (40, 42, 70 and 81 kDa). We conclude that g ± T cells can undergo tyrosine phosphorylation of the appropriate target substrates after TCR±CD3 triggering, although with slightly unsustained kinetics for some proteins.
Discussion
Effects of HVS on T cell signaling
HVS-transformed T cells have proved to be a good model system to study T lymphocyte physiopathology (38) . The fact that they are pure antigen-and mitogen-independent homogeneous cell lines, as well as their growth kinetics, makes them particularly suited for biochemical and functional studies of congenital human T cell disorders, where enough blood samples are a major ethical hurdle (20) . However, the effect of HVS on T cell signal transduction has to be considered in relation to our observations. HVS infection transforms lymphocytes into autocrine antigen-independent growth by means of only two constitutive viral proteins, tyrosine kinase-interacting protein (Tip) and HVS transformation-associated protein of C strains (Stp-C) (39) . Both viral proteins interact with, and Fig. 4 . Defective PMA-induced TCR±CD3 down-regulation in g-de®cient T cells (A) is not due to the selective internalization of putative g-containing TCR±CD3 isoforms in g-suf®cient T cells (B). (A) CD4 + (left) or CD8 + (right) g ± (empty squares) and g + (®lled squares) T cells were analyzed by¯ow cytometry for the expression of CD3 (Leu4) in response to increasing amounts of PMA for 30 min (top) or to 20 ng/ml of PMA in a kinetic analysis (bottom). Results are given relative to unstimulated cells. Only consistent differences between g ± T cells and at least three unrelated g + controls are shown. (B) g ± and g + CD8 + cells were treated with PMA where indicated (+), monitored with Leu4 for TCR down-regulation relative to untreated cells (±), radioiodinated, lysed, immunoprecipitated with APA 1/1 (anti-CD3) and digested, where indicated (+), with N-glycanase (N-Gly) before electrophoresis. CD3g:CD3d ratios were estimated by electronic densitometry of the corresponding deglycosylated (dg) proteins (Q100). Arrows mark the position of normal proteins in g cells. Note that, prior to deglycosylation, CD3d from g ± samples runs close to the expected position for normal CD3g, as described (20) . Fig. 5 . Increased CD3-and lectin-induced apoptosis in g-de®cient T cells. (A) g ± (empty squares) and g + (®lled squares) CD4 + T cells were analyzed by¯ow cytometry for the induction of apoptosis (A) and necrosis (N) in response to 1 mg/ml plastic-bound anti-CD3 (UCHT1), 10 ng/ml PMA plus 750 ng/ml ionomycin (PMA + ionomycin) or 1 mg/ml PHA in a kinetic experiment. Cell death results are given relative to unstimulated cells as means T SD of three independent experiments where a g ± and a g + T cell line were compared. Only consistent differences between g ± T cells and at least three unrelated g + controls are shown. (B) Representative FACS pro®les of treated and untreated g + and g ± cells at the last time point (48 h) illustrate that g ± T cells are more prone to enter apoptosis by membrane stimuli. Apoptosis (A) and necrosis (N) were distinguished among Annexin V cells by their resistance or susceptibility to propidium iodide staining respectively. probably activate, the cytosolic host signaling proteins Lck and Ras (38) . Therefore, viral interference may change or even restore the original signaling defects. It has been reported that HVS restored certain CD2-and CD3-mediated signaling dysfunctions in Zap-70-de®cient T cells, such as calcium ux, MAPK activation, cytokine production and proliferation (40) . However, activation-induced tyrosine phosphorylation of z remained defective in the same study and others have shown that a subset of primary Zap-70-de®cient T cells in fact already have partially restored CD3-induced responses (24) . Therefore, rather than actually restore signaling as a sideeffect of transformation on any given T cell, HVS may confer a selective growth advantage in vitro to those primary T cells which were originally different anyway. Indeed, restored signaling correlated with high content of the Zap-70-related Syk protein tyrosine kinase, both in transformed and in primary Zap-70-de®cient T cells. CD45RO overexpression in transformed, but not primary, CD8 + g ± cells (Fig. 1) could be due to a similar mechanism. Together, available evidence indicates that, if anything, HVS could restore, but not cause, T cell signaling defects, so that we may be under-rather than overestimating the contribution of CD3g to TCR±CD3 regulation and signaling. The present work identi®ed TCR±CD3-induced mature T cell responses which require the involvement of CD3g, and distinguished them from other responses where CD3g seems redundant. Alternatively, the affected responses may require a higher signaling strength, which the mutant TCR±CD3 complex is unable to deliver.
Contribution of CD3g to surface TCR±CD3 regulation
The results presented herein demonstrate that high numbers of g ± TCR±CD3 complexes reach the cell surface and can be down-regulated by anti-CD3, but not by PMA (Fig. 3 and 4) . Preserved ligand-induced TCR±CD3 down-regulation has also been reported in fresh g ± PBL (41) and con®rms a wealth of data showing that ligand-induced TCR±CD3 internalization may be mediated by CD3 chains other than g (28) . However, the extent of receptor down-regulation in CD3g-de®cient T cells was consistently lower than in normal cells (Fig. 3) , indicating that CD3g contributes to, but is not absolutely required for, TCR±CD3 down-regulation, as shown in Jurkat g ± T cell mutants (42) . These results contrast with those recently published in murine g ± peripheral blood lymphocytes showing no ligand-induced TCR±CD3 down-regulation (11) . Further studies will be required to settle this discrepancy, although inter-species differences in the regulation of TCR±CD3-mediated signaling cannot be discarded. In this regard, it is known that the peripheral T cell compartment of humans is less affected than that of mice by the lack of CD3g or e (5).
Defective PMA-induced TCR±CD3 down-regulation in the absence of CD3g is consistent with the crucial role demonstrated in this process for certain phosphoserine-dependent leucine-based endocytic signals mapping to the cytosolic tail of CD3g (22) . Constitutive TCR±CD3 internalization and recycling in unstimulated T cells is believed to be controlled also by serine phosphorylation of CD3g (43) . Therefore, the lower basal TCR±CD3 expression observed in unstimulated T cells (Fig. 1) could be due to an impaired assembly rate, as internalization and recycling should be absent or reduced (44, 45) . Our previous biochemical results which demonstrated an impaired association of g ± TCR±CD3 to CD3z support this contention (18, 20, 46) . Experiments are underway to test this hypothesis. Alternatively, or in addition, CD3g could improve the stability or accessibility of the TCR±CD3 complex.
Contribution of CD3g to TCR±CD3-mediated signaling
Following receptor engagement, we observed normal (CD71 and CD80) or slightly delayed (CD3, CD4, CD8 and CD25) regulation of different cell surface molecules (Figs 2 and 3) . However, LFA-1-dependent adhesion was decreased (Fig. 6 ) and apoptosis was increased (Fig. 5) , perhaps as a consequence of an unsustained phosphorylation of downstream substrates (Fig. 7) . Our previous studies in human CD3g-de®cient primary T cells, IL-2-dependent T cell lines and HVStransformed T lymphocytes indicated that, despite its negative effect on TCR±CD3 expression, CD3g is dispensable for several TCR±CD3-induced mature T cell responses, including calcium¯ux, cytotoxicity, CD69 or CD154 up-regulation, proliferation and synthesis of certain cytokines (TNF-a). In contrast, PMA-induced TCR±CD3 down-regulation and TCR± CD3-induced synthesis of other cytokines (IL-2) were severely impaired (17±20). Normal, reduced, delayed or abrogated T cell responses have also been reported in murine mature CD3g-de®cient fresh T lymphocytes (11) . For instance, relatively normal proliferation, cytokine production and cytolysis were observed in the murine model under certain conditions, whereas suboptimal kinetics or stimuli revealed defective responses. However, these assays were performed using fresh lymphocytes, which contain a variable mixture of heterogeneous CD4 + and CD8 + cells, the percentage of which may differ from normal controls, as reported in the human homologues (16) . For instance, murine g ± lymphocyte samples contained relatively more CD8 + and less CD4 + cells compared to controls (11) . Transformed T cells are clearly more homogeneous (Fig.1 ) and therefore allow a more precise molecular dissection of the signaling circuitry of T cells, albeit only for those responses that are preserved. This characteristic may explain, at least in part, the minor discrepancies between fresh human or murine g ± T cells and the results that we obtained using pure transformed T cells.
Taken together, these results and our previously published data (19) suggest a specialized contribution by CD3g to certain T cell responses, such as adhesion or IL-2 induction, and a redundant role for other responses, such as proliferation, cytotoxicity or TNF-a induction. Alternatively, these differential functional outcomes could result from the impaired TCR±CD3 expression (11) , structural instability (20) or inef®-cient signaling. However, we believe that this is unlikely for several reasons. First, despite their differences in surface TCR±CD3 (Fig. 1) , CD4 + and CD8 + g ± T cells showed a similar regulation of different cell surface molecules (CD3, CD71, CD4 and CD8, see Figs 2 and 3) , and other functional responses (19) . Second, pure g ± T cells stimulated in identical conditions can show normal or defective responses, such as TNF-a versus IL-2 cytokine induction (see above). Third, TCRstimulated d ± murine thymocytes showed impaired activation of the ERK, but not JNK or p38, pathway when compared to normal control cells selected for comparable TCR expression levels (12) , suggesting that this differential signaling is not related to the surface numbers or structure of TCR complexes, Obviously, a quantitative interpretation cannot be excluded. Lack of g may decrease signal strength by the mutant TCR± CD3 and affect those responses requiring higher signaling thresholds. However, this seems unlikely in view that quantitative control of TCR±CD3 levels in transgenic mice has shown that reduced TCR levels results in attenuated responses, but also in markedly reduced response thresholds in terms of TCR numbers (as low as 1/20th of normal) (47) .
The early intracellular propagation of signals through the mutant TCR±CD3 complex requires further investigation. Calcium¯ux was normal (19, 20) , but tyrosine phosphorylation kinetics was slightly altered (Fig. 7) . Particularly relevant to our results is the recent report demonstrating that the TCRproximal transmembrane adaptor termed TRIM can inhibit TCR±CD3 internalization and apoptosis, and regulate the cytoskeleton through its interaction with CD3z and, to a lesser extent, with CD3e and CD3g (48, 49 ). An impaired association of TRIM to the mutant g ± TCR±CD3 complex (perhaps, again, as a consequence of its impaired association to CD3z, see above) may potentially result in low constitutive TCR±CD3 expression (Fig. 1) , high TCR±CD3-induced apoptosis (Fig. 5) , and defective cell adhesion and cytoskeleton control (Fig. 6) . In this regard, murine g ± T cells have been proposed to be more prone to activation-induced cell death in vivo as a consequence of impaired signal extinction due to defective TCR down-regulation (11) .
The complex interactions of the TCR with the cytoskeleton are an area of intense research (50, 51) . g ± T cells showed no TCR±CD3-or PDBu-induced cell polarization, whereas LFA-1-induced morphological changes were present, although with delayed kinetics. As the actin cytoskeleton has an important role in LFA-1-dependent polarization (32), the results suggest that CD3g is required for, or participates in, the induction of actin polymerization not only through the TCR±CD3, but probably indirectly through the LFA-1 integrin as well (33) . Indeed, LFA-1-induced T cell migration has been shown to require Zap-70, which is crucial for TCR±CD3 signaling (52) . In addition, LFA-1-induced T cell polarization, but not adhesion, can be blocked with tyrosine kinase inhibitors (33) . The virtual absence of TCR±CD3 down-regulation using the PKC activator PMA (Fig. 4) correlates with this dissociated behavior, and suggests that PKC-induced cell polarization (but not adhesion, Fig. 6 ) requires rapid TCR±CD3 internalization. In human T cells, mutations in downstream effectors such as WASP also result in impaired actin polymerization (53) , suggesting that CD3g is required for the ef®cient coupling of the TCR to these cytoskeleton activation pathways, perhaps through stabilization of CD3z (see above).
Our results indicate that CD3g contributes specialized structural and signaling functions, which may improve certain TCR±CD3-induced mature T cell responses. Such specialized features may be essential for survival under certain circumstances, as dramatically illustrated by a CD3g-de®cient patient who died before his third birthday (17) . This particular patient showed a severe lymphoid depletion at necropsy (54) , which may be related to the observed defects in T cell adhesion control (Fig. 6 ). More often, however, signaling is suf®cient for protection, as two additional g ± individuals are presently healthy and over their ®rst decade (16 
